by Ashley | Oct 1, 2021 | Blog, Clinical Trial, COVID-19, Stem Cell Therapy
For those who follow our blog, you are probably aware that Personalized Stem Cells (PSC) developed and received FDA approval for a COVID-19 stem cell clinical trial in 2020. We then went on to out-license this clinical trial, along with our allogeneic stem cell...
by Ashley | Jun 11, 2021 | Blog, Clinical Trial, COVID-19
Lately, it seems, we are sharing updates regarding the COVID-19 cell therapy product and clinical trial every other week. The developments seem to be coming at a breakneck speed, as is warranted when faced with a crisis like the COVID-19 pandemic. Our latest news...
by Ashley | Jun 1, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell
Personalized Stem Cells, Inc (PSC), an adipose-derived stem cell company, announces the Brazilian Health Regulatory Agency (Anvisa) authorized a Phase 2 COVID-19 stem cell clinical trial. This approval comes shortly after the completion of a Phase 1b trial conducted...
by Ashley | May 4, 2021 | Clinical Trial, COVID-19, Press Release, Stem Cell
Just three months after the initial treatments, Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, announces enrollment is complete for COVID-19 FDA approved stem cell clinical trial licensed to Sorrento Therapeutics (Nasdaq: SRNE,...
by Ashley | Apr 30, 2021 | Blog, Clinical Trial, COVID-19
In February, we announced preliminary results in a COVID-19 stem cell clinical trial that we licensed to Sorrento Therapeutics. To give a bit of backstory for those who may be new to our blog, Personalized Stem Cells went to work in the early pandemic days to...
by Ashley | Apr 16, 2021 | Blog, Clinical Trial, Knee Osteoarthritis
We have more exciting news regarding our FDA approved stem cell clinical trial for knee osteoarthritis! In January, Personalized Stem Cells announced that data collection for the clinical trial was complete. (You can read that blog here.) Recently, we announced that...
